234
Participants
Start Date
October 31, 2014
Primary Completion Date
January 31, 2016
Study Completion Date
January 31, 2016
ferric citrate
1 g ferric citrate containing approximately 210 mg of ferric iron
Placebo
Matching placebo
Nephrology Associates of Northern VA, Inc., Fairfax
Mendez Center for Clinical Research, Alexandria
Peninsula Kidney Associates, Hampton
Metrolina Nephrology, Charlotte
Mountain Kidney & Hypertension Associates, Asheville
Kidney Care Associates, LLC, Augusta
Renal Physicians of Georgia, PC, Macon
Creekside Medical Research, DeLand
Riverside Clinical Research, Edgewater
Pines Clinical Research, Inc, Pembroke Pines
Renaissance Renal Research, Detroit
Michigan Kidney Consultants, PC, Pontiac
Advanced Renal Care, Evergreen Park
Clinical Research Consultants, Kansas City
Kansas Nephrology Research Institute, Wichita
Lincoln Nephrology & Hypertension, Lincoln
Renal Associates of Baton Rouge, Baton Rouge
TAD Clinical Research, Lufkin
Kidney & Hypertension Specialists, San Antonio
Clinical Advancement Center, San Antonio
San Antonio Kidney Disease Center, San Antonio
Research Management, Inc, Austin
Research Management, Inc., Austin
Denver Nephrology, Denver
Pacific Renal Research Institute, Meridian
AKDHC Medical Research Services, LLC, Phoenix
Southwest Kidney Institute, Tempe
Sierra Nevada Nephrology Asoociates, Reno
Academic Medical Research Institute, Inc, Los Angeles
Southern California Medical Research Center, La Palma
California Renal Research, Glendale
La Jolla Clinical Research, Inc, San Diego
California Institute of Renal Research, San Diego
Apex Research of Riverside, Riverside
Capital Nephrology Medical Group, Sacramento
Western New England Renal & Transplant Associates, Springfield
Lead Sponsor
Keryx Biopharmaceuticals
INDUSTRY